Pay in 4 interest-free payments of $5.95 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Plus, its safer and more controlled than synthetic growth hormone injections
Key Leaders: Nathan Hubbard, CEO Number of Employees: More than 2,500 Stage: Acquired Financial Snapshot: Valued at $1.9 billion during acquisition Notable Investors: Roche, Google Ventures (GV), Allen & Company, Baillie Gifford, and Casdin Capital Key Product: Flatiron Health offers OncoEMR, an electronic medical record (EMR) system that helps medical teams manage patient data and treatment plans and streamline internal workflows
Additionally, it is a commercially valuable one
Skin cancer rates are higher in men partly due to lower rates of sun protection, and regular skin checks for changing moles or lesions are worthwhile
Is there downtime
